imatinib mesylate has been researched along with Seizures in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Singh, S; Singh, TG | 1 |
Dohgu, S; Hashiguchi, K; Itoh, K; Kataoka, Y; Sakai, K; Takata, F; Tominaga, K; Yamanaka, G; Yamauchi, A; Yasunaga, M | 1 |
Bornhäuser, M; Dresemann, G; Ehninger, G; Hosius, C; Illmer, T; Nikolova, Z; Prondzinsky, R; Pursche, S; Said, SM; Schleyer, E; von Bonin, M; Wang, Y | 1 |
3 other study(ies) available for imatinib mesylate and Seizures
Article | Year |
---|---|
Imatinib Attenuates Pentylenetetrazole Kindled and Pilocarpine Induced Recurrent Spontaneous Seizures in Mice.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; Imatinib Mesylate; Mice; Pentylenetetrazole; Pilocarpine; Seizures; Status Epilepticus; Valproic Acid | 2023 |
Reactive pericytes in early phase are involved in glial activation and late-onset hypersusceptibility to pilocarpine-induced seizures in traumatic brain injury model mice.
Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Disease Susceptibility; Gene Expression; Hippocampus; Imatinib Mesylate; Male; Mice, Inbred C57BL; Neuroglia; Pericytes; Pilocarpine; Receptor, Platelet-Derived Growth Factor beta; Seizures; Time Factors | 2021 |
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain Neoplasms; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Female; Glioblastoma; Humans; Hydroxyurea; Imatinib Mesylate; Isoenzymes; Male; Middle Aged; Piperazines; Pyrimidines; Seizures; Young Adult | 2008 |